Important topics in pediatric dermatology will be reviewed and updated including beta blockade for the treatment of hemangiomas; new topical and systemic medications for atopic dermatitis; and approaches to common cutaneous infections including warts and molluscum.
Describe two new therapeutic options for AD in children released within the last 12 months.
Evaluate the off label usage of these new agents in young children.
Discuss emerging agents in the pipeline for pediatric dermatologic patients.
Professor, Department of Pediatrics; Chief, Division of Dermatology SCH/UWSOM,
Seattle Children's Hospital/University of Washington School of Medicine
You must be logged in and own this session in order to